On January 26, 2024, the Board of Directors of Boston Scientific Corporation appointed Jonathan Monson as Senior Vice President, Investor Relations, effective March 1, 2024. Mr. Monson currently serves as Senior Vice President, Global Controller and Chief Accounting Officer, a position he has held since July 2019; effective March 1, 2024, Mr. Monson will no longer serve as the Company?s Chief Accounting Officer. Also on January 26, 2024, the Board appointed Emily Woodworth (Collins), age 46, as Senior Vice President, Global Controller and Chief Accounting Officer, effective March 1, 2024.

Ms. Woodworth currently serves as Vice President of Finance and Controller of the Company?s Urology business, a position she has held since July 2019. Prior to serving in her current role, Ms. Woodworth was Director of Global Technical Accounting and External Reporting at the Company from April 2016 through July 2019, and prior to that, served as Controller and Finance Director for the Company?s Cork, Ireland manufacturing plant and Neuromodulation business, respectively.